News Category AllAll ReleasesRegulatory Releases Year All2024202320222021202020192018 August 29, 2024 Oculis to Present at Upcoming September Investor Conferences August 27, 2024 Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update August 15, 2024 Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer July 30, 2024 Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference June 27, 2024 Oculis and EURETINA Announces the Ramin Tadayoni Award June 10, 2024 Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy June 4, 2024 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities May 30, 2024 Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board May 17, 2024 Oculis updates share capital for its existing at-the-market offering program May 8, 2024 Oculis Reports Q1 2024 Financial Results and Provides Company Updates
July 30, 2024 Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
June 10, 2024 Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
June 4, 2024 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
May 30, 2024 Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board
